Document Detail

Twelve-month follow-up results of a trial utilizing axxent electronic brachytherapy to deliver intraoperative radiation therapy for early-stage breast cancer.
MedLine Citation:
PMID:  20737219     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Accelerated partial breast irradiation (APBI) is emerging as a valid alternative to whole-breast radiation therapy (WBRT) in breast-conserving therapy (BCT) for early-stage breast cancer. Axxent electronic brachytherapy (EBX) is a form of portable, balloon-based APBI that utilizes an electronic source of kilovoltage irradiation delivery with minimal shielding requirements. As such, EBX becomes a logical and convenient modality for delivery of intraoperative radiation therapy (IORT). We report 1-year results and clinical outcomes of a trial that utilizes EBX to deliver IORT for patients with early-stage breast cancer.
METHODS: Eleven patients were enrolled on an institutional review board (IRB)-approved protocol. Inclusion criteria were patient age >45 years, unifocal tumors with infiltrating ductal or ductal carcinoma in situ (DCIS) histology, tumors ≤3 cm, and uninvolved lymph nodes. Preloaded radiation plans were used to deliver radiation prescription dose of 20 Gy to the balloon surface.
RESULTS: The mean time for radiation delivery was 22 min; the total mean procedure time was 1 h 39 min. All margins of excision were negative on final pathology. At mean follow-up of 12 months, overall cosmesis was excellent in 10 of 11 patients. No infection, fat necrosis, desquamation, rib fracture or cancer recurrence has been observed. There was no evidence of fibrosis at last follow-up.
CONCLUSION: IORT utilizing EBX is emerging as a feasible, well-tolerated alternative to postsurgical APBI. Further research and longer follow-up data on EBX and other IORT methods are needed to establish the clinical efficacy and safety of this treatment.
Olga Ivanov; Adam Dickler; Bennett Y F Lum; James V Pellicane; Darius S Francescatti
Related Documents :
19895279 - P53 and gamma radiation in the normal breast.
11491279 - Radiation dose monitoring in a breast cancer patient with a pacemaker: a case report.
18506399 - Molecular markers of radiation-related normal tissue toxicity.
16556059 - The mammosite breast brachytherapy device: targeted delivery of breast brachytherapy.
10948399 - The effects of circulating antigen on the pharmacokinetics and radioimmunoscintigraphic...
19163289 - Radiation effects in interventional radiology using biological and physical dosimetry m...
24325759 - Combined usage of intercostal nerve block and tumescent anaesthesia: an effective anaes...
25480329 - Stensen's duct carcinoma with a papillary architecture.
22090419 - Plumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolyti...
Publication Detail:
Type:  Journal Article     Date:  2010-08-25
Journal Detail:
Title:  Annals of surgical oncology     Volume:  18     ISSN:  1534-4681     ISO Abbreviation:  Ann. Surg. Oncol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9420840     Medline TA:  Ann Surg Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  453-8     Citation Subset:  IM    
Department of Surgery, Little Company of Mary Hospital, Evergreen Park, IL, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy.
Next Document:  Brain Perfusion in Adult Patients with Acute Myeloblastic Leukemia before and after Cytosine Arabino...